Table 1.
Prosthetic joint infection | Aseptic failure | |
---|---|---|
No. of patients | 29 | 58 |
Age (range) | 70 (54–88) | 70 (29–86) |
No. of females | 12 | 44 |
No. of males | 17 | 14 |
Joint | ||
Knee | 12 | 29 |
Hip | 17 | 29 |
First revision | 20 | 39 |
Repeated revision | 9 | 19 |
Median no. of samples retrieved (range) | 6 (5–8) | 6 (5–10) |
Time of implant failure | ||
Early (0–3 months] | 6 | 0 |
Delayed (3–24 months) | 6 | 19 |
Late (< 24 months) | 17 | 39 |
Median time of prosthesis in vivo, months (range) | 36 (0–213) | 45 (5–270) |
Median time of transport, h (range) | 1:30 (0:32–18:40) | 1:49 (0:40–3:29) |
Median ESR (range), mm/h | 80 (0–81) | 3 (0–30) |
Median CRP (range), mg/L | 62 (15–170) | 9 (0–165) |
Histology: no. of patients with >5 PMN/HPF | 16 | 4 |
Antimicrobial therapy before operation | 8 | 3 |
ESR: erythrocyte sedimentation rate; CRP: C-reactive protein;
PMN: polymorphonuclear neutrophils; HPF: high-power field.